Strategic collaborations are vital for the overall growth of the smart pills market, as these collaborations help increase the influence of the players in the market. The players are involved in mergers, acquisitions, joint ventures, and partnerships. Furthermore, the investment levels in the smart pills market are rapidly growing. The rising popularity of smart pills among the populace attracts several investors. Various companies and investment firms are investing heavily in mergers, acquisitions, and startups. These factors can help boost the growth of the smart pills market. Collaborations agreements between research institutions & companies, licensing agreements & partnerships among companies, and augmented R&D investment in smart pills are a few other factors boosting the market growth. For instance, in January 2021, etectRx, Inc. entered into a partnership agreement with Pear Therapeutics, Inc. to develop two product candidates in the CNS space integrating adherence sensors and prescription digital therapeutics (PDTs). This is the first of its kind partnership in exploring the usage of digital pill solutions with PDTs. In August 2020, Otsuka acquired Proteus Digital Health, the smart pill manufacturer, for US$ 15 million.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the smart pills market. The Europe smart pills market is expected to grow at a good CAGR during the forecast period.
Europe Smart Pills Market Segmentation
The Europe smart pills market is segmented based on application, disease indication, and end user.Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the Europe smart pills market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.
Europe Smart Pills Market – Companies Mentioned
Medtronic; PENTAX Medical; Olympus Corporation; BodyCap; and Otsuka Holdings Co., Ltd are among the leading companies in the Europe smart pills market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 934.08 Million |
| Market Size by 2028 | US$ 2,054.19 Million |
| CAGR (2021 - 2028) | 11.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Application
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
1.Medtronic
2.PENTAX Medical
3.Olympus Corporation
4.BodyCap
5.Otsuka Holdings Co., Ltd.
The Europe Smart Pills Market is valued at US$ 934.08 Million in 2021, it is projected to reach US$ 2,054.19 Million by 2028.
As per our report Europe Smart Pills Market, the market size is valued at US$ 934.08 Million in 2021, projecting it to reach US$ 2,054.19 Million by 2028. This translates to a CAGR of approximately 11.9% during the forecast period.
The Europe Smart Pills Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Smart Pills Market report:
The Europe Smart Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Smart Pills Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Smart Pills Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)